Is parexel a good company?
Great place to work. Like every job has its ups and downs but overall it’s a great place with great management. Also has great benefits and 401k. Would recommend.
What type of company is parexel?
biopharmaceutical services
PAREXEL International Corporation is a global biopharmaceutical services The Company provides contract research, consulting, medical communications, and technology solutions. The Company provides its services to the worldwide pharmaceutical, biotechnology, and medical device industries.
What is parexel known for?
Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process.
Who owns parexel?
EQT IX Fund
Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion. Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
Is Syneos health a good company?
Great place to work, very flexible Syneos is a pretty big company but the team I work with is awesome. I’ve gotten the support I need from my managers, work from home and I have the flexibility I need. As long as work is done and meetings and deadlines met there is no issues. Very happy here!
Is Parexel a Fortune 500 company?
Figures are for fiscal year ended June 30, 2016….Company Info.
| CEO | Josef H. von Rickenbach |
|---|---|
| Website | http://www.parexel.com |
| Years on Fortune 500 List | – |
| Employees | 18,600 |
Is Parexel a CRO?
Parexel is in the business of improving the world’s health. As a leading CRO, we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.
Has Parexel been sold?
Parexel sold to EQT and Goldman Sachs for $8.5 billion.
Is Calyx owned by Parexel?
Calyx will be privately held by the same ownership group that has owned Parexel since 2017. Calyx will be led by Chief Executive Officer Gavin Nichols and the company will be headquartered in Nottingham, United Kingdom, and Durham, North Carolina. The new organization will employ approximately 2,300 employees.
Which company is better cognizant or IQVIA?
IQVIA employees rated their CEO Approval 12% higher than Cognizant Technology Solutions employees rated theirs. IQVIA employees rated their Positive Business Outlook 10% higher than Cognizant Technology Solutions employees rated theirs.
Is IQVIA stressful?
Excellent work culture. Although work is stressful but enjoyable along with great work life balance. Flexible and Employee friendly.
How is PAREXEL in the business of Medicine?
At the heart of getting medicines to those who need them. Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access,…
How many employees does Parexel have in the world?
Headquartered near Boston, Massachusetts and in Durham, North Carolina, Parexel has over 17,000 employees, with offices that support clients in over 100 countries around the world. Supporting clients in more than 100 countries, our company is united by one simple fact. We care. We’re not just the people with brains, we’re the people with heart.
What kind of strategy does Parexel biotech use?
In drug development, early and simultaneous management of commercial, clinical, regulatory, and market access strategy is the surest path to approval, investment, reimbursement, and market share. Get the Parexel Biotech perspective on early strategies for bringing new treatments to the patients who need them.
Who is the head of heor at PAREXEL?
Provides strategic direction and clinical insights that inform Medical Affairs communication planning across a broad array of… Katarzyna heads up Parexel’s HEOR division with 20 years’ experience in healthcare and health economics. She is a Professor…